PFIZER INC — Director's Dealing 2019

Feb 27, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PFIZER INC (PFE)
CIK: 0000078003
Period of Report: 2019-02-23

Reporting Person: MACKENZIE ALEXANDER R (Executive Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-02-23	Common Stock	M	41615.0000	$21.0300	Acquired	144164.0000	Direct
2019-02-23	Common Stock	F	12925.0000	$42.9600	Disposed	131239.0000	Direct
2019-02-23	Common Stock	F	12958.0000	$41.9100	Disposed	118281.0000	Direct
2019-02-25	Common Stock	F	2759.0000	$43.0800	Disposed	115522.0000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-02-23	Stock Appreciation Rights	$21.0300	M	41615.0000	Disposed	2019-02-23	Common Stock (41615.0000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	9338.0000	Indirect

Footnotes

F1: The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).

F2: The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.

F3: Price is the closing price of Pfizer common stock on February 22, 2019

F4: The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).

F5: Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.

F6: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon).